Extended, delayed and immediate release formulation method of manufacturing and use thereof
US10792261B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Sep 14, 2018 |
| Grant date | Oct 6, 2020 |
| Priority date | — |
| Expiry date | Nov 4, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions for reducing the frequency of urination and methods of manufacturing the compositions are disclosed. The compositions comprises a first component having an immediate-release subcomponent and an extended-release subcomponent, wherein the first component is formulated to release the subcomponents immediately after administration; and a second component comprising an immediate-release subcomponent and an extended-release subcomponent, wherein the second component is formulated for a delayed-release of the subcomponents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.